Barbara W. Durkacz

4.7k total citations · 2 hit papers
38 papers, 3.6k citations indexed

About

Barbara W. Durkacz is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Barbara W. Durkacz has authored 38 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 20 papers in Oncology and 5 papers in Genetics. Recurrent topics in Barbara W. Durkacz's work include DNA Repair Mechanisms (17 papers), PARP inhibition in cancer therapy (14 papers) and Cancer therapeutics and mechanisms (8 papers). Barbara W. Durkacz is often cited by papers focused on DNA Repair Mechanisms (17 papers), PARP inhibition in cancer therapy (14 papers) and Cancer therapeutics and mechanisms (8 papers). Barbara W. Durkacz collaborates with scholars based in United Kingdom, United States and Australia. Barbara W. Durkacz's co-authors include Sydney Shall, Paul Nurse, Douglas A. Gray, Olusesan Omidiji, David Beach, Stephany Veuger, Nicola J. Curtin, Graeme C.M. Smith, Michael J. Tilby and Antony M. Carr and has published in prestigious journals such as Nature, The EMBO Journal and Blood.

In The Last Decade

Barbara W. Durkacz

38 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

(ADP-ribose)n participates in DNA excision repair

1980 920 citations Barbara W. Durkacz et al. Nature profile →
Functionally homologous cell cycle control genes in budding and fission yeast

1982 345 citations David Beach, Barbara W. Durkacz et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara W. Durkacz United Kingdom	25	2.9k	1.7k	365	360	272	38	3.6k
Irina Gromova Denmark	37	2.7k 0.9×	794 0.5×	343 0.9×	591 1.6×	306 1.1×	83	3.8k
Jo Milner United Kingdom	31	2.4k 0.8×	1.7k 1.0×	249 0.7×	494 1.4×	238 0.9×	57	3.5k
Anna Sablina Belgium	29	2.7k 0.9×	1.1k 0.7×	462 1.3×	717 2.0×	243 0.9×	51	3.6k
Karen A. Cadwallader United Kingdom	21	2.6k 0.9×	781 0.5×	792 2.2×	295 0.8×	568 2.1×	28	3.7k
Petra Beli Germany	32	3.8k 1.3×	907 0.5×	770 2.1×	475 1.3×	419 1.5×	71	4.7k
Benjamin Nicholson United States	28	2.4k 0.8×	1.0k 0.6×	219 0.6×	289 0.8×	295 1.1×	58	3.3k
Christin Tse United States	22	3.5k 1.2×	882 0.5×	220 0.6×	252 0.7×	415 1.5×	24	4.3k
Patricia A. Solski United States	27	3.6k 1.2×	1.1k 0.6×	1.2k 3.2×	429 1.2×	320 1.2×	34	4.6k
Antony W. Oliver United Kingdom	32	2.5k 0.8×	1.1k 0.7×	433 1.2×	211 0.6×	192 0.7×	72	3.0k
Lisa Wiesmüller Germany	42	4.6k 1.6×	2.4k 1.4×	668 1.8×	824 2.3×	434 1.6×	136	5.8k

Countries citing papers authored by Barbara W. Durkacz

Since Specialization

Citations

This map shows the geographic impact of Barbara W. Durkacz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara W. Durkacz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara W. Durkacz more than expected).

Fields of papers citing papers by Barbara W. Durkacz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara W. Durkacz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara W. Durkacz. The network helps show where Barbara W. Durkacz may publish in the future.

Co-authorship network of co-authors of Barbara W. Durkacz

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara W. Durkacz. A scholar is included among the top collaborators of Barbara W. Durkacz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara W. Durkacz. Barbara W. Durkacz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hunter, Jill V., Elaine Willmore, Julie Irving, et al.. (2011). NF-κB mediates radio-sensitization by the PARP-1 inhibitor, AG-014699. Oncogene. 31(2). 251–264. 34 indexed citations

Elliott, Sarah L., Evan A. Mulligan, Geoffrey Summerfield, et al.. (2010). Mitoxantrone in combination with an inhibitor of DNA‐dependent protein kinase: a potential therapy for high risk B‐cell chronic lymphocytic leukaemia. British Journal of Haematology. 152(1). 61–71. 28 indexed citations

Veuger, Stephany & Barbara W. Durkacz. (2010). Persistence of unrepaired DNA double strand breaks caused by inhibition of ATM does not lead to radio-sensitisation in the absence of NF-κB activation. DNA repair. 10(2). 235–244. 14 indexed citations

Willmore, Elaine, Sarah L. Elliott, Tryfonia Mainou‐Fowler, et al.. (2008). DNA-Dependent Protein Kinase Is a Therapeutic Target and an Indicator of Poor Prognosis in B-Cell Chronic Lymphocytic Leukemia. Clinical Cancer Research. 14(12). 3984–3992. 73 indexed citations

Veuger, Stephany, Jill V. Hunter, & Barbara W. Durkacz. (2008). Ionizing radiation-induced NF-κB activation requires PARP-1 function to confer radioresistance. Oncogene. 28(6). 832–842. 108 indexed citations

Willmore, Elaine, Sarah L. Elliott, Geoffrey Summerfield, et al.. (2008). DNA-Dependent Protein Kinase Is a Therapeutic Target in Poor Prognosis B-Cell Chronic Lymphocytic Leukemia. Blood. 112(11). 382–382. 1 indexed citations

Cowell, Ian G., Nicola J. Sunter, Prim B. Singh, et al.. (2007). γH2AX Foci Form Preferentially in Euchromatin after Ionising-Radiation. PLoS ONE. 2(10). e1057–e1057. 183 indexed citations

Cowell, Ian G., Barbara W. Durkacz, & Michael J. Tilby. (2005). Sensitization of breast carcinoma cells to ionizing radiation by small molecule inhibitors of DNA-dependent protein kinase and ataxia telangiectsia mutated. Biochemical Pharmacology. 71(1-2). 13–20. 51 indexed citations

Boulton, Simon J., Suzanne Kyle, & Barbara W. Durkacz. (2000). Mechanisms of enhancement of cytotoxicity in etoposide and ionising radiation-treated cells by the protein kinase inhibitor wortmannin. European Journal of Cancer. 36(4). 535–541. 27 indexed citations

10.

Kyle, Suzanne, et al.. (1996). Wortmannin is a potent inhibitor of DNA double strand break but not single strand break repair in Chinese hamster ovary cells. Carcinogenesis. 17(11). 2285–2290. 109 indexed citations

11.

Griffin, Robert, Nicola J. Curtin, David R. Newell, et al.. (1995). The role of inhibitors of poly(ADP-ribose) polymerase as resistance-modifying agents in cancer therapy. Biochimie. 77(6). 408–422. 78 indexed citations

12.

Jones, Suzanne F., Elaine Willmore, & Barbara W. Durkacz. (1994). The effects of 5-fluoropyrimidines on nascent DNA synthesis in Chinese hamster ovary cells monitored by pH-step alkaline and neutral elution. Carcinogenesis. 15(11). 2435–2438. 5 indexed citations

13.

Willmore, Elaine & Barbara W. Durkacz. (1993). Cytotoxic mechanisms of 5-fluoropyrimidines. Biochemical Pharmacology. 46(2). 205–211. 16 indexed citations

14.

Durkacz, Barbara W., John Lunec, Helen M. Grindley, et al.. (1992). Murine melanoma cell differentiation and melanogenesis induced by poly(ADP-ribose) polymerase inhibitors. Experimental Cell Research. 202(2). 287–291. 7 indexed citations

15.

Moses, Kevin, Adrian L. Harris, & Barbara W. Durkacz. (1988). Adenosine-diphosphoribosyltransferase inhibitors can protect against or potentiate the cytotoxicity of S-phase acting drugs. Biochemical Pharmacology. 37(11). 2155–2160. 11 indexed citations

16.

Moses, Kevin, Adrian L. Harris, & Barbara W. Durkacz. (1988). Synergistic enhancement of 6-thioguanine cytotoxicity by ADP-ribosyltransferase inhibitors.. PubMed. 48(20). 5650–4. 12 indexed citations

17.

Durkacz, Barbara W., Antony M. Carr, & Paul Nurse. (1986). Transcription of the cdc2 cell cycle control gene of the fission yeast Schizosaccharomyces pombe. The EMBO Journal. 5(2). 369–373. 73 indexed citations

18.

Beach, David, Barbara W. Durkacz, & Paul Nurse. (1982). Functionally homologous cell cycle control genes in budding and fission yeast. Nature. 300(5894). 706–709. 345 indexed citations breakdown →

19.

Durkacz, Barbara W., et al.. (1981). The Effect of Inhibition of (ADP‐ribose)_n Biosynthesis on DNA Repair Assayed by the Nucleoid Technique. European Journal of Biochemistry. 121(1). 65–69. 78 indexed citations

20.

Watson, David H., Barbara W. Durkacz, & David J. Sherratt. (1978). Homologous Regions of Colicins E1 and K and Colicins E2 and E3. Biochemical Society Transactions. 6(6). 1257–1259. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact